Endoscopic ultrasound in gastric cancer staging before and after neoadjuvant chemotherapy. A comparison with PET-CT in a clinical series.

No Thumbnail Available

Date

2016-12-12

Authors

Redondo-Cerezo, Eduardo
Martínez-Cara, Juan Gabriel
Jiménez-Rosales, Rita
Valverde-López, Francisco
Caballero-Mateos, Antonio
Jérvez-Puente, Pablo
Ariza-Fernández, Jose Luis
Úbeda-Muñoz, Margarita
López-de-Hierro, Mercedes
de Teresa, Javier

Advisors

Journal Title

Journal ISSN

Volume Title

Publisher

Metrics
Google Scholar
Export

Research Projects

Organizational Units

Journal Issue

Abstract

Treatment of gastric cancer is based on accurate staging. Emerging methods, such as PET-CT, are increasingly being used for this purpose. Our aim was to analyze the results of EUS and PET-CT in staging and restaging our patients with gastric cancer, comparing both of them with the histological results. Patients with confirmed gastric cancer were prospectively enrolled. Inclusion criteria for the final analysis included only patients who finally received a surgical resection. All patients underwent preoperative TNM staging by means of EUS and PET-CT within 21 days prior to the surgical treatment. A total of 256 patients were included. The overall EUS accuracy for T staging was 78% and 80.2% in restaging. EUS showed its best accuracy when distinguishing T1-T2 tumors vs. T3-T4, with an increased accuracy in restaging. Regarding N staging, the overall accuracy of EUS was 76.2%, and 72.5% for PET-CT (p = 0.02). With regards to restaging, accuracy of EUS and PET-CT for N staging was 88.5% and 69%, respectively, with significant differences (p  EUS performed better than PET-CT in gastric cancer N staging and restaging. EUS accuracy in this setting is still suboptimal and probably more than one single diagnostic procedure should be used.

Description

MeSH Terms

DeCS Terms

CIE Terms

Keywords

EUS, Gastric cancer staging, PET-CT, gastric preoperative evaluation, restaging

Citation